ArticleBiomedicines2021

Short-Term SGLT2 Inhibitor Administration Does Not Alter Systemic Insulin Clearance in Type 2 Diabetes.

Motonori Sato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.